Lynx MD, an Israeli medtech startup that offers an artificial intelligence AI based platform for real world clinical and operational data collaboration, raised $12 million in Seed financing in a round led by MizMaa Ventures with participation from New York Life Ventures, Amdocs, and iAngels, as well as existing investors Triventures, UpWest and notable angels.
Lynx MD boasts that its cloud-based platform unlocks real-world health data, at scale. The company says that it enables the sharing and analysis of rich, unstructured data, securely connecting healthcare organizations with the life sciences and med-tech community, while eliminating risk to patient privacy. Our cloud-based platform provides an environment for deep learning studies, enabling researchers to investigate data from a multiplicity of sources, driving innovation.
“We are accelerating innovation by bringing together a network of partners – from academic healthcare systems, community health centers and specialty practices to med-tech and pharma companies and academics. All benefit from the power of collaboration and the confidence of security and privacy.”
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
Israel is known as the startup state or Startup Nation. The country has had multi-billion dollar exits for numerous software and security companies. But Startup Nation is also known for its medtech startups. Israel has always been a center for medical research and innovation. Now put that together with its startup culture and you have medtech nation.
“AI and machine learning models are only as good as the data which feeds them. Quality, variety and volume of the data are key,” said Omer Dror, co-founder and CEO of Lynx. “This is especially true and important in the healthcare industry where people’s lives are at stake. AI has incredible potential to help researchers, drug developers, and doctors discover new ways to improve patient outcomes and the healthcare industry overall, but only if we solve the data access conundrum.”